Plan staffing and rota cover appropriate to demand in post-market medicine surveillance.
Post-Market Surveillance of Medicine Safety
A concise, decision-focused programme covering post-market medicine surveillance end to end.
📍 Abu Dhabi🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
The data supporting post-market medicine surveillance is usually present but rarely assembled into a decision. In healthcare, a weakness in the practice within health and pharmaceutical services is eventually paid for by a patient. Most organisations already have a policy on the health and pharmaceutical services discipline; far fewer can show it working. Participants apply post-market medicine surveillance to their own clinical service throughout, so the output is directly usable. The material serves both public bodies and commercial organisations dealing with this part of health and pharmaceutical services. They acquire practical criteria for judging when this area of health and pharmaceutical services is working and when it is only appearing to. It establishes a shared vocabulary for post-market medicine surveillance so that teams can disagree productively about it. Practitioner evidence points the same way: this strand of health and pharmaceutical services improves fastest where responsibility for it is named and owned. The course ends by identifying what the participant will stop doing to make this aspect of health and pharmaceutical services sustainable.
Expected Learning Outcomes
Build continuing professional development sustaining competence in post-market medicine surveillance.
Draw practical lessons from failures in post-market medicine surveillance without assigning blame that suppresses reporting.
Communicate the purpose of post-market medicine surveillance to those who have to comply with it.
Verify that improvements to post-market medicine surveillance have held six months after they were introduced.
Prepare the documented evidence accreditation assessors expect on post-market medicine surveillance.
Apply regulatory and licensing requirements governing post-market medicine surveillance.
Who Should Attend
Infection prevention and control practitioners covering post-market medicine surveillance.
Clinical department heads responsible for post-market medicine surveillance.
Hospital and health facility managers accountable for post-market medicine surveillance.
Project and programme managers whose delivery depends on post-market medicine surveillance.
Planning staff whose forecasts and budgets are affected by post-market medicine surveillance.
Regulatory affairs specialists handling post-market medicine surveillance.
Course Modules
Post-market medicine surveillance: clinical process design and workflow
2 sessions · 8 pointsSession 1Investigating an adverse event involving post-market medicine surveillance
- Apply structured root cause analysis to the last adverse event involving post-market medicine surveillance.
- Define escalation criteria for deterioration detected through post-market medicine surveillance.
- Prepare the summary of post-market medicine surveillance that senior management will read.
- Close the loop: confirm changes to post-market medicine surveillance improved the indicator they targeted.
Session 2Reading the current state of post-market medicine surveillance honestly
- Build medication safety checks into post-market medicine surveillance at the point of highest risk.
- Set out the decisions in post-market medicine surveillance that require sign-off and by whom.
- Confirm that reporting on post-market medicine surveillance reaches the people who can act.
- Test the procedure for post-market medicine surveillance against a realistic scenario.
Post-market medicine surveillance: incident reporting, investigation and learning
2 sessions · 8 pointsSession 1What patients actually experience during post-market medicine surveillance
- Check that records of post-market medicine surveillance answer the questions likely to be asked.
- Decide what will be stopped to create capacity for post-market medicine surveillance.
- Confirm patient data handled within post-market medicine surveillance meets confidentiality obligations.
- Identify single points of dependency in post-market medicine surveillance and reduce them.
Session 2Keeping supply and cold chain reliable for post-market medicine surveillance
- Check that consent processes within post-market medicine surveillance are genuinely informed.
- Match staffing levels on post-market medicine surveillance to measured demand across the week.
- Reduce the variation in how post-market medicine surveillance is carried out between teams.
- Draft the minimum viable clinical protocol for post-market medicine surveillance.
Post-market medicine surveillance: confidentiality, consent and ethics
2 sessions · 8 pointsSession 1Consent, confidentiality and ethics in post-market medicine surveillance
- Reduce unwarranted variation in post-market medicine surveillance between shifts and sites.
- Confirm that contractual obligations around post-market medicine surveillance are understood.
- Collect evidence on the present handling of post-market medicine surveillance before proposing changes.
- Establish the boundary of post-market medicine surveillance and record what sits outside it.
Session 2Designing post-market medicine surveillance so it helps rather than obstructs care
- Arrange the handover of post-market medicine surveillance so capability survives staff changes.
- Verify cold chain and storage conditions for materials used in post-market medicine surveillance.
- Assemble the accreditation evidence pack for post-market medicine surveillance.
- Confirm that those complying with post-market medicine surveillance understand why it exists.
Post-market medicine surveillance: cost, efficiency and sustainability of the service
2 sessions · 8 pointsSession 1The hard cases in post-market medicine surveillance and how to reason about them
- Agree what will be standardised in post-market medicine surveillance and what will not.
- Audit post-market medicine surveillance by observing practice, not by reading policy.
- Identify infection transmission risks created by post-market medicine surveillance and control them.
- Select quality indicators for post-market medicine surveillance that measure outcome rather than activity.
Session 2What to measure in post-market medicine surveillance and what to ignore
- Confirm licensing and regulatory requirements applying to post-market medicine surveillance are met.
- Confirm competence and continuing development for staff delivering post-market medicine surveillance.
- Review whether post-market medicine surveillance is aligned with the objectives of the clinical service.
- Map the clinical workflow for post-market medicine surveillance as it is actually performed.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.